Cannabis trial: Basel pharmacies to charge black-market prices
The first Swiss project on the legal sale of cannabis in pharmacies will start on September 15 in canton Basel City. Hemp users over 18 can now register to take part, with the number of participants limited to 370.
This content was published on
1 minute
Keystone-SDA/ts/ug
Español
es
Test: Venta de cannabis en farmacias suizas a precios de mercado negro
Six cannabinoid products – four types of cannabis flowers and two types of hashish – will be sold in nine pharmacies selected by the authorities, cantonal health minister Lukas Engelberger said on Thursday.
The prices charged by the pharmacies will be around those charged on the black market for products with a THC content. A gram will therefore cost CHF8-CHF12 ($8.40-$12.60).
The Federal Office of Public Health approved the pilot in April. It will be part of a project by the University of Basel, its psychiatric clinics and the cantonal health department.
It is intended to help evaluate the effects of new regulations on the recreational use of cannabis and ultimately combat black market distribution.
Legal ban
Several other local authorities, including Zurich, Geneva and Bern, have also applied to roll out similar trials. The Swiss parliament laid the legal basis for such small-scale initiatives in September 2020.
The health office estimates there are 220,000 regular consumers of cannabis in Switzerland despite a legal ban. The use of cannabis is only allowed for medical reasons.
In 2008 almost two-thirds of Swiss voters rejected an initiative to decriminalise cannabis consumption; it was the second national vote on the issue in a decade.
More
More
Swiss cannabis market – a delicate balancing act
This content was published on
Producing and selling hemp inflorescences with low THC content has been legal in Switzerland since 2017. But the market hasn’t been a gold mine.
Is artificial intelligence an advantage or a disadvantage for workers?
What is your experience with AI at work? Have you already used it? Has it helped you work better? Or has it caused you more stress, more work or caused you to lose your job? Tell us about your experiences!
Swiss price watchdog slams excessive prices for generic medicines
This content was published on
The cheapest generic medicines available in Switzerland are more than twice as expensive as in other countries, according to a study by the Swiss price watchdog.
Nature should not figure in net zero calculations: academic study
This content was published on
The natural removal of CO2 from the atmosphere by forests or oceans should not be included in the net-zero balance of climate protection measures, argue researchers.
This content was published on
None of the 15 major Swiss retail banks is meeting international climate and biodiversity targets, according to a ranking by WWF Switzerland.
This content was published on
Nestlé's new CEO Laurent Freixe, has presented plans for the future of the world's largest food company, after his first few weeks in office.
Swiss foreign minister calls on Moscow to end Ukraine war
This content was published on
It's high time Moscow ended its war against Ukraine, Swiss foreign minister Ignazio Cassis tells the UN Security Council.
This content was published on
The only alternative to the UN Palestinian agency’s work in Gaza is to allow Israel to run services there, Philippe Lazzarini, UNRWA Commissioner-General, told reporters in Geneva on Monday.
Study reveals food culture differences between Switzerland and neighbours
This content was published on
Three-quarters of Swiss people consider eating to be a pleasurable, social activity, a new survey reveals. Healthy eating, however, plays a much less important role, it found.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Health office approves first Swiss project to sell cannabis for recreational use
This content was published on
The city of Basel is the first to be given the green light by the Swiss authorities for a scientific trial with cannabis for recreational use.
Majority of Swiss support the legalisation of cannabis
This content was published on
Nearly two-thirds of people surveyed want the minimum age of consumption to be set at 18, the Federal Office of Public Health (FOPH) said. Two-thirds are in favor of conducting pilot tests on the controlled distribution of cannabis for recreational purposes. The survey was conducted by the Sotomo Institute from the end of January to…
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.